Ceftriaxone PharmSol

Medicinal product

(Invented) name

Ceftriaxone PharmSol

Active substance (s)

Ceftriaksonas

Strength

1000 mg

Pharmaceutical form

milteliai injekciniam ar infuziniam tirpalui

Route (s) of administration

leisti į veną, leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01DD04, Ceftriaxone

Marketing authorisation holder

PharmSol Europe Limited, Malta

Date of authorisation

2021-07-23

Date of renewal

Documents

4791 Ceftriaxone PharmSol RPP 2022 08 11.docx

4791 Pakuotės lapelis 2022 08 11.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

MT/H/0278/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Flakone yra:	1 vnt.
Ceftriaksonas	1000 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
106906	93009	1093009	flakonas	N1		Receptinis	LT/1/21/4791/001	Netiekiama	-	-	No	-	-
106907	93010	1093010	flakonas	N5		Receptinis	LT/1/21/4791/002	Netiekiama	-	-	No	-	-
106908	93011	1093011	flakonas	N55 (11×5)		Receptinis	LT/1/21/4791/003	Netiekiama	-	-	No	-	-
106909	93012	1093012	flakonas	N55		Receptinis	LT/1/21/4791/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-07-23	Registruotas